Sam Brusco, Associate Editor03.01.23
Medical 3D printing and planning solutions provider Materialise began a collaboration with Exactech to provide advanced treatment options for patients with severe shoulder defects. Exactech will include Materialise Glenius in its portfolio to enable surgeons to help patients with personalized implants in Europe and Australia.
Orthopedic surgeons can use Materialise’s personalized implants to treat patients with substantial glenoid bone loss, for whom standard and augmented shoulder implants wouldn’t lead to sustainable results.
“By including the Materialise Glenius implant into our existing offering, we’re providing surgeons in Europe and Australia access to an even more extensive shoulder portfolio,” said Chris Roche, Exactech’s sr. VP, Extremities told the press. “We are happy to partner with Materialise to bring greater personalization and additional artificial intelligence technology to shoulder reconstruction.”
Glenius implants are designed based on the patient’s anatomy using 3D data, simulation, and artificial intelligence. Optimizing the implant’s fixation and stability while maximizing bone preservation aims to achieve more predictable outcomes in challenging eroded glenoid scenarios.
“Demand is growing in the orthopedic industry for personalization of medical devices,” said Brigitte de Vet, VP, Medical at Materialise. “Medical device companies adopt mass personalization by starting with high-value use cases and moving towards more high-volume applications. Materialise is dedicated to enabling researchers, engineers, and clinicians to revolutionize patient-specific treatment that improves clinical outcomes.”
Orthopedic surgeons can use Materialise’s personalized implants to treat patients with substantial glenoid bone loss, for whom standard and augmented shoulder implants wouldn’t lead to sustainable results.
“By including the Materialise Glenius implant into our existing offering, we’re providing surgeons in Europe and Australia access to an even more extensive shoulder portfolio,” said Chris Roche, Exactech’s sr. VP, Extremities told the press. “We are happy to partner with Materialise to bring greater personalization and additional artificial intelligence technology to shoulder reconstruction.”
Glenius implants are designed based on the patient’s anatomy using 3D data, simulation, and artificial intelligence. Optimizing the implant’s fixation and stability while maximizing bone preservation aims to achieve more predictable outcomes in challenging eroded glenoid scenarios.
“Demand is growing in the orthopedic industry for personalization of medical devices,” said Brigitte de Vet, VP, Medical at Materialise. “Medical device companies adopt mass personalization by starting with high-value use cases and moving towards more high-volume applications. Materialise is dedicated to enabling researchers, engineers, and clinicians to revolutionize patient-specific treatment that improves clinical outcomes.”